This invention relates to a use of a fermented Glycine max (L.) extract prepared by fermenting a Glycine max (L.) extract in inducing autophagy in a subject. In particular, the fermented Glycine max (L.) extract can be used in preventing and/or treating a disease in which in a subject, such as cancer, diabetes neurodegeneration, steatohepatitis and aging. The invention also relates to a use of the fermented Glycine max (L.) extract in inducing apoptosis in combination with autophagy in a subject.
展开▼
机译:本发明涉及通过发酵 Glycine max I>(L。)提取物制备的发酵的 Glycine max I>(L。)提取物在诱导个体自噬中的用途。特别地,发酵的 Glycine max I>(L。)提取物可用于预防和/或治疗对象的疾病,例如癌症,糖尿病神经变性,脂肪性肝炎和衰老。本发明还涉及发酵的 Glycine max I>(L。)提取物在与自噬结合的受试者中诱导细胞凋亡的用途。
展开▼